SELARL PHARMACIE LESAGE : revenue, balance sheet and financial ratios

SELARL PHARMACIE LESAGE is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VERS-PONT-DU-GARD (30210), this company of category PME shows in 2016 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE LESAGE (SIREN 503176224)
Indicator 2021 2020 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C N/C 1 470 840 € 1 515 835 €
Net income 92 906 € 110 908 € 84 285 € 109 785 € 121 286 € 102 061 € 116 296 €
EBITDA N/C N/C N/C N/C N/C 149 763 € 172 654 €
Net margin N/C N/C N/C N/C N/C 6.9% 7.7%

Revenue and income statement

In 2021, SELARL PHARMACIE LESAGE generates positive net income of 93 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2021: 116 k€ -> 93 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

92 906 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

53.004%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.873%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

79.9%

Solvency indicators evolution
SELARL PHARMACIE LESAGE

Sector positioning

Debt ratio
53.0 2021
2019
2020
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Good

In 2021, the debt ratio of SELARL PHARMACIE LESAGE (53.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
60.87% 2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Good

In 2021, the financial autonomy of SELARL PHARMACIE LESAGE (60.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 435.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

435.098

Liquidity indicators evolution
SELARL PHARMACIE LESAGE

Sector positioning

Liquidity ratio
435.1 2021
2019
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.61
Excellent

In 2021, the liquidity ratio of SELARL PHARMACIE LESAGE (435.10) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE LESAGE

Positioning of SELARL PHARMACIE LESAGE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of SELARL PHARMACIE LESAGE is estimated at 1 065 670 € (range 685 231€ - 1 646 125€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
685k€ 1065k€ 1646k€
1 065 670 € Range: 685 231€ - 1 646 125€
NAF 5 année 2021

Valuation method used

Net Income Multiple
92 906 € × 11.5x = 1 065 671 €
Range: 685 231€ - 1 646 126€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE LESAGE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE LESAGE

What is the revenue of SELARL PHARMACIE LESAGE ?

The revenue of SELARL PHARMACIE LESAGE in 2016 is 1.5 M€.

Is SELARL PHARMACIE LESAGE profitable?

Yes, SELARL PHARMACIE LESAGE generated a net profit of 93 k€ in 2021.

Where is the headquarters of SELARL PHARMACIE LESAGE ?

The headquarters of SELARL PHARMACIE LESAGE is located in VERS-PONT-DU-GARD (30210), in the department Gard.

Where to find the tax return of SELARL PHARMACIE LESAGE ?

The tax return of SELARL PHARMACIE LESAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE LESAGE operate?

SELARL PHARMACIE LESAGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.